Although cholesteatoma was first described in 1683, its etiopathogeny remains unexplained.
In children, there are two forms: acquired cholesteatoma, resembling the adult form, and …

Cholesteatoma is a cystic non tumorous lesion of the temporal bone that has the ability to
destroy nearby structures by its power to cause bone resorption and as a result, fatal …

The differential involvement of the macrophage activation phenotypes (M1 vs. M2) has been
linked to disease severity in various chronic inflammatory disorders. Pharmacologic …

Introduction: Residual disease after cholesteatoma removal is still a challenge for the
otorhinolaryngologist. Scheduled “second-look” surgery and, more recently, radiological …

Objective: To investigate the JAK/STAT pathway in the middle ear mucosa in patients with
acquired cholesteatoma compared with middle ear mucosa from healthy controls. Design …

Gracias al descubrimiento de los antibióticos, la incidencia de complicaciones en las otitis
medias agudas y crónicas ha descendido significativamente, aunque continúan siendo un …

Abstract Objectives/Hypothesis: Keratinocytes harvested from acquired cholesteatoma and
grown in cell culture will demonstrate increased interleukin‐8 (IL‐8) production in response …

Objective: This study aims to analyze the use of RNA amplification tests to evaluate the
expression of MMP and TIMP isoforms in cholesteatomas and their correlation with disease …

Introducción: El colesteatoma es una entidad clínica que se presenta principalmente en
edades medias de la vida. El tratamiento definitivo es quirúrgico, el cual apunta a erradicar …

This study details our series of intracranial epidermoid cysts. A historical cohort of 110
epidermoid cysts that were excised from intracranial location over a 16 year period was …